Ligand Pharmaceuticals Inc (LGND)
Interest Expense
$6.19M
TTM · Period ending: · USD
LGND Interest Expense
Latest reported$6.19Mperiod ending
Latest reported$6.19Mperiod ending
LGND TTM Interest Expense ($0.00 → $6.19M)
TTM interest expense
High-resolution chart · PNG
LGND interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 6,190,000 | |
| 5,595,000 | |
| 4,715,000 | |
| 3,813,000 | |
| 3,644,000 | |
| 3,759,000 | |
| 3,033,000 | |
| 2,281,000 | |
| 1,541,000 | |
| 557,000 | |
| 656,000 | |
| 765,000 | |
| 1,096,000 | |
| 1,250,000 | |
| 1,799,000 | |
| 6,031,000 | |
| 10,138,000 | |
| 14,583,000 | |
| 19,625,000 | |
| 21,543,000 | |
| 23,373,000 | |
| 24,703,000 | |
| 27,420,000 | |
| 29,864,000 | |
| 32,588,000 | |
| 35,387,000 | |
| 35,745,000 | |
| 47,054,000 | |
| 49,261,000 | |
| 53,703,000 | |
| 48,277,000 | |
| 30,909,000 | |
| 23,095,000 | |
| 12,982,000 | |
| 12,443,000 | |
| 12,674,000 | |
| 12,404,000 | |
| 12,114,000 | |
| 12,178,000 | |
| 12,099,000 | |
| 11,913,000 | |
| 11,831,000 | |
| 11,799,000 | |
| 11,786,000 | |
| 10,372,000 | |
| 7,584,000 | |
| 4,859,000 | |
| 2,267,000 | |
| 1,145,000 | |
| 1,417,000 | |
| 2,081,000 | |
| 2,604,000 | |
| 2,945,000 | |
| 3,339,000 | |
| 3,219,000 | |
| 3,089,000 | |
| 3,054,000 | |
| 2,881,000 | |
| 2,512,000 | |
| 1,816,000 | |
| 1,124,000 | |
| 463,000 | |
| 58,000 | |
| 52,000 | |
| 65,000 | |
| 94,000 | |
| 270,000 | |
| 257,000 | |
| 236,000 | |
| 194,000 | |
| 52,000 | |
| 52,000 | |
| 52,000 | |
| 52,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |